Session 1: Pharmacotherapy Of Central Nervous System Disorders: Part 1-Schizophrenia And Alzheimer’s

Date: 10/20/2010 Check-In and Breakfast:
7:00 am - 7:30 am
Educational Session: 7:30 am - 12:30 pm
Edward Fisher, Ph.D.,R.Ph. Professor of Pharmacology and Toxicology and Associate Dean for Academic Affairs University of Hawaii at Hilo College of Pharmacy 	
, Live CME Instructor for University Learning Systems
Edward Fisher, Ph.D.,R.Ph. Professor of Pharmacology and Toxicology and Associate Dean for Academic Affairs University of Hawaii at Hilo College of Pharmacy

At the conclusion of this presentation, the participant will be able to:

  • Describe the typical course of the disease processes associated with schizophrenia and Alzheimer’s disease
  • State the diagnostic criteria used for schizophrenia and Alzheimer’s.
  • State the various subtypes of schizophrenia and stages of cognitive decline associated with Alzheimer’s disease.
  • Describe the various clinical symptoms associated with of the both disease states.
  • Describe the prognosis and epidemiology of the both disease states.
  • Explain the current theories on the etiology of schizophrenia and Alzheimer’s.
  • Describe how to implement the current medical treatment for both disease states.
  • State the pharmacological properties of the drugs used to treat these disorders.
  • List the adverse effects associated with the drugs commonly used to treat these disorders.